EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Box–Behnken Design of Experiments of Polycaprolactone Nanoparticles Loaded with Irinotecan Hydrochloride

Basant Salah Mahmoud iD, Christopher McConville

Pharmaceutics · 18.04.2023 · 15 (4) · 1271

DOI: 10.3390/pharmaceutics15041271 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 18.04.2023. Verfasst von Basant Salah Mahmoud und 1 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, College of Medical and Dental Sciences, University of Birmingham, Birmingham B15 2TT, UK. Die Arbeit wurde bisher 54-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Egyptian government.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The Box–Behnken design of experiments (BBD) is a statistical modelling technique that allows the determination of the significant factors in developing nanoparticles (NPs) using a limited number of runs. It also allows the prediction of the best levels of variables to obtain the desired characteristics (size, charge, and encapsulation efficiency) of the NPs. The aim of this study was to examine the effect of the independent variables (amount of polymer and drug, and surfactant concentration) and their interaction on the characteristics of the irinotecan hydrochloride (IRH)-loaded polycaprolactone (PCL) NPs and to determine the most optimum conditions for producing the desired NPs.

Methods

The development of the NPs was carried out by a double emulsion solvent evaporation technique with yield enhancement. The NPs data were fitted in Minitab software to obtain the best fit model.

Results

By using BBD, the most optimum conditions for producing the smallest size, highest magnitude of charge, and highest EE% of PCL NPs were predicted to be achieved by using 61.02 mg PCL, 9 mg IRH, and 4.82% PVA, which would yield 203.01 nm, −15.81 mV, and 82.35% EE.

Conclusion

The analysis by BBD highlighted that the model was a good fit to the data, confirming the suitability of the design of the experiments.

Schlagwörter

Stichwörter der Autor:innen

Box–Behnkendesign of experimentsencapsulation efficiencyirinotecan hydrochloridenanoparticlespolycaprolactonesizeyieldzeta potential

Autor:innen und Institutionen

  • School of Pharmacy, College of Medical and Dental Sciences, University of Birmingham, Birmingham B15 2TT, UK.
  • Hormones Department, Institute of Medical Research and Clinical Studies, National Research Centre, El Buhouth St., Dokki, Cairo 12622, Egypt.

ORCID-Profile: Basant Salah Mahmoud

Förderung

  • Egyptian government

Zitieren

APA

Mahmoud, B. S., & McConville, C. (2023). Box–Behnken Design of Experiments of Polycaprolactone Nanoparticles Loaded with Irinotecan Hydrochloride. Pharmaceutics, 15(4), 1271. https://doi.org/10.3390/pharmaceutics15041271

Vancouver

Mahmoud BS, McConville C. Box–Behnken Design of Experiments of Polycaprolactone Nanoparticles Loaded with Irinotecan Hydrochloride. Pharmaceutics. 2023;15(4):1271. doi:10.3390/pharmaceutics15041271

BibTeX
@article{Mahmoud2023,
  author = {Mahmoud, Basant Salah and McConville, Christopher},
  title = {Box–Behnken Design of Experiments of Polycaprolactone Nanoparticles Loaded with Irinotecan Hydrochloride},
  journal = {Pharmaceutics},
  year = {2023},
  volume = {15},
  number = {4},
  pages = {1271},
  doi = {10.3390/pharmaceutics15041271}
}
Kostenlos starten →